Literature DB >> 18374182

Ras-driven transformation of human nestin-positive pancreatic epithelial cells.

Paul M Campbell1, Kwang M Lee, Michel M Ouellette, Hong Jin Kim, Angela L Groehler, Vladimir Khazak, Channing J Der.   

Abstract

Mutational activation of the K-Ras oncogene is well established as a key genetic step in the development and growth of pancreatic adenocarcinomas. However, the means by which aberrant Ras signaling promotes uncontrolled pancreatic tumor cell growth remains to be fully elucidated. The recent use of primary human cells to study Ras-mediated oncogenesis provides important model cell systems to dissect this signaling biology. This chapter describes the establishment and characterization of telomerase-immortalized human pancreatic duct-derived cells to study mechanisms of Ras growth transformation. An important strength of this model system is the ability of mutationally activated K-Ras to cause potent growth transformation in vitro and in vivo. We have utilized this cell system to evaluate the antitumor activity of small molecule inhibitors of the Raf-MEK-ERK mitogen-activated protein kinase cascade. This model will be useful for genetic and pharmacologic dissection of the contribution of downstream effector signaling in Ras-dependent growth transformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374182     DOI: 10.1016/S0076-6879(07)00431-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  9 in total

1.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

2.  Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.

Authors:  Sabiha Kazim; Mokenge P Malafa; Domenico Coppola; Kazim Husain; Sherma Zibadi; Trinayan Kashyap; Marsha Crochiere; Yosef Landesman; Tami Rashal; Daniel M Sullivan; Amit Mahipal
Journal:  Mol Cancer Ther       Date:  2015-05-01       Impact factor: 6.261

3.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

4.  Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis.

Authors:  Yoko Matsuda; Zenya Naito; Kiyoko Kawahara; Nando Nakazawa; Murray Korc; Toshiyuki Ishiwata
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

5.  TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.

Authors:  Paul M Campbell; Nadia Boufaied; James J Fiordalisi; Adrienne D Cox; Pierre Falardeau; Channing J Der; Henriette Gourdeau
Journal:  J Mol Signal       Date:  2010-11-02

6.  K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.

Authors:  Yoichi Matsuo; Paul M Campbell; Rolf A Brekken; Bokyung Sung; Michel M Ouellette; Jason B Fleming; Bharat B Aggarwal; Channing J Der; Sushovan Guha
Journal:  Mol Cancer Res       Date:  2009-06-09       Impact factor: 5.852

7.  Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.

Authors:  J I Alexander; D B Vendramini-Costa; R Francescone; T Luong; J Franco-Barraza; N Shah; J C Gardiner; E Nicolas; K S Raghavan; E Cukierman
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

8.  Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells.

Authors:  Haley L Peters; Amit Tuli; Xiaojian Wang; Cuiling Liu; Zenggang Pan; Michel M Ouellette; Michael A Hollingsworth; Richard G Macdonald; Joyce C Solheim
Journal:  Int J Oncol       Date:  2012-07-13       Impact factor: 5.650

9.  MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Sumit Arora; Nikhil Tyagi; Seema Singh; Joel Andrews; Steve McClellan; Bin Wang; Ajay P Singh
Journal:  Br J Cancer       Date:  2015-08-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.